![Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2119136921/2089647169/gr1.gif)
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology
![PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318 PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318](https://image2.slideserve.com/3905318/xeloda-simplifying-the-complexity-of-treatment-for-metastatic-colorectal-cancer-mcrc-l.jpg)
PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318
![Xeloda Cost Price in Phillipines | Buy Generic Capecitabine Drugs | To treat breast colon or rectal cancer | Available in Vietnam Ireland UK UAE India Xeloda Cost Price in Phillipines | Buy Generic Capecitabine Drugs | To treat breast colon or rectal cancer | Available in Vietnam Ireland UK UAE India](https://cancermedicinesnetwork.com/stomach-cancer/images/xeloda.jpg)
Xeloda Cost Price in Phillipines | Buy Generic Capecitabine Drugs | To treat breast colon or rectal cancer | Available in Vietnam Ireland UK UAE India
![PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318 PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318](https://image2.slideserve.com/3905318/xeloda-is-an-ideal-combination-partner-for-cytotoxic-and-biological-agents-l.jpg)